The COVID Machine

In the early weeks of 2020, a novel coronavirus was spreading across the world. The public, understandably frightened, turned to its institutions for guidance. Those institutions responded, but not always with honesty. Some of what they said was wrong from the beginning and demonstrably so. Some of what they suppressed was correct. Some of what they attacked as dangerous misinformation was subsequently validated by the government's own data. And the individuals who asked the most obvious questions were not elevated. They were censored, mocked, threatened with the loss of their medical licenses, and subjected to coordinated campaigns of institutional ridicule.

What the Intelligence Community Concluded

The official position of the American government, for much of 2020 and 2021, was that the COVID-19 pandemic almost certainly arose from natural transmission of a virus from animals to humans, and that the hypothesis of a laboratory origin was a fringe theory unworthy of serious investigation. That position has since been contradicted by multiple agencies of the American government itself, though the intelligence community remains divided.

In February 2023, FBI Director Christopher Wray stated publicly that the FBI had assessed with moderate confidence that the pandemic most likely originated from a Chinese government-controlled laboratory.¹ The FBI was not alone. The Department of Energy, which oversees America's national laboratories, also concluded that a laboratory leak was the most likely origin of the pandemic, with low confidence. The Wall Street Journal reported the DOE's assessment in February 2023, and the finding was subsequently confirmed.² It should be noted that four other U.S. intelligence entities, plus the National Intelligence Council, assessed natural origin as more likely, also with low confidence, indicating no government consensus on the question.

The Senate Health, Education, Labor and Pensions Committee staff had reached the same conclusion in their October 2022 interim report, finding after extensive review of available evidence that the most likely origin of the pandemic was a laboratory incident at the Wuhan Institute of Virology.³ A Senate subcommittee investigation in 2023 specifically examined how federal agencies had actively obscured rather than investigated this possibility.

The Lancet Letter and the Conflict It Did Not Disclose

On February 19, 2020, The Lancet published a statement signed by twenty-seven scientists dismissing the laboratory origin hypothesis as a conspiracy theory. The statement declared that scientists overwhelmingly concluded that this coronavirus originated in wildlife. It was organized and coordinated by Peter Daszak, the president of EcoHealth Alliance, a nonprofit organization that had received NIH funding to conduct bat coronavirus research at the Wuhan Institute of Virology.

Daszak did not disclose this connection in the letter. He had a direct and obvious financial and institutional interest in the conclusion that the virus had not originated in a laboratory that his own organization had helped fund and whose research he had publicly championed. The Lancet did not add an editor's note disclosing Daszak's conflict of interest until June 2021, sixteen months after the original publication.⁴ The Lancet's editor-in-chief subsequently acknowledged that he had been aware of Daszak's links to the Wuhan laboratory throughout that period. By the time the disclosure appeared, the letter had served its purpose: it had been widely cited by media organizations as scientific consensus that the lab leak hypothesis was not credible.

The Private Emails and the Public Paper

On February 1, 2020, a group of virologists, including Dr. Kristian Andersen of the Scripps Research Institute, had a teleconference with Anthony Fauci and Francis Collins of NIH. In the days before that call, Andersen had emailed Fauci privately to express concern that features of the virus looked potentially engineered, describing it as inconsistent with evolutionary theory.⁵

On March 17, 2020, six weeks after that private communication, Andersen was the lead author of a paper in Nature Medicine titled "The proximal origin of SARS-CoV-2." The paper concluded that the virus was not a laboratory construct and that natural origin was most likely. It became the most widely cited scientific paper dismissing the lab leak hypothesis, and Fauci cited it publicly at a White House briefing.⁶

The emails between Andersen, Fauci, and Collins were released in 2021 through Freedom of Information Act requests obtained by Buzzfeed News and The Intercept. They documented that Andersen had privately expressed significant concern about engineered features of the virus, within days of his private communication with the man who oversees the funding of his institution's research. Andersen has maintained that his team's concerns were resolved through further scientific analysis before the paper was published. The documents raised questions that the scientific establishment did not answer publicly or transparently.

The Research and the Researchers

The connection between American academic research and the Wuhan Institute of Virology is not a theory. It is documented in published scientific papers and NIH grant records. Ralph Baric, a virologist at the University of North Carolina Chapel Hill, is one of the world's leading experts on bat coronaviruses. Shi Zhengli, the chief bat coronavirus researcher at the Wuhan Institute of Virology, is his longtime scientific collaborator. Their joint work was published in peer-reviewed journals and partially funded by American taxpayer money.⁷

In November 2015, Baric, Shi Zhengli, and colleagues published a paper in Nature Medicine demonstrating that chimeric bat coronaviruses, viruses constructed by combining genetic elements from different strains, could infect human airway cells using the same receptor pathway as the original SARS virus. This research, conducted partly at UNC-Chapel Hill and partly at WIV, was funded in part through NIH grants channeled through EcoHealth Alliance.

The Moratorium That Was Not Enforced

On October 17, 2014, the Obama administration's Office of Science and Technology Policy announced a moratorium on federal funding for gain-of-function research, defined as research that could make a pathogen more dangerous by increasing its transmissibility, lethality, or immune evasion. The moratorium was announced in response to a series of biosafety incidents at American laboratories that had alarmed the scientific community.⁸

EcoHealth Alliance continued to receive NIH funding during and after the moratorium period. The NIH maintained, for years, that the research it funded at WIV through EcoHealth Alliance did not meet the definition of gain-of-function research covered by the moratorium. That position became significantly harder to sustain after October 2021.

On October 20, 2021, Lawrence Tabak, the Principal Deputy Director of the NIH, sent a letter to Representative James Comer of the House Oversight Committee. The letter acknowledged that EcoHealth Alliance had conducted research at WIV that had produced bat coronaviruses with enhanced capabilities, and that EcoHealth Alliance had failed to report these results to NIH as required. The letter stated plainly that the research had met the definition of enhanced potential pandemic pathogen research.⁹

The Testimony and What the Documents Said

On May 11, 2021, Anthony Fauci testified before the Senate HELP Committee that the NIH had not funded gain-of-function research at the Wuhan Institute of Virology. Senator Rand Paul of Kentucky challenged that testimony directly, citing the published Baric-Shi paper and the EcoHealth Alliance grant documentation. Fauci maintained his position under oath.

Five months later, the Tabak letter to Congress directly complicated that testimony. The NIH's own correspondence confirmed that the research funded at WIV through EcoHealth Alliance had involved enhancement of bat coronavirus capabilities. Senator Paul's exchanges with Fauci on this question, conducted over multiple hearings and now part of the Congressional Record, document one of the most significant conflicts between sworn testimony and subsequently released documentary evidence in recent congressional history.

Masks: The Private Opinion and the Public Guidance

On February 5, 2020, Anthony Fauci sent an email to Sylvia Burwell, the former Secretary of Health and Human Services. The email, released through FOIA in 2021, states that the masks people buy in drug stores are not really effective at keeping out the virus. One month later, on March 8, 2020, Fauci appeared on CBS News's 60 Minutes and told the public there was no reason to be walking around with a mask.¹⁰

Fauci subsequently reversed this position and became one of the most visible advocates for universal masking, at times recommending the simultaneous wearing of two masks. He later explained that he had initially discouraged public mask-wearing in part to preserve the supply of N95 respirators for healthcare workers. Whatever the rationale, the public received different guidance than the private assessment the documentary record shows he held.

The scientific literature has not been kind to universal masking mandates. In January 2023, the Cochrane Collaboration published an updated systematic review of physical interventions to reduce the spread of respiratory viruses. The review examined randomized controlled trials and found that wearing masks in the community probably makes little or no difference to influenza-like illness outcomes, including COVID-19.¹¹ Cochrane's editor-in-chief subsequently clarified that the review's findings were inconclusive rather than definitive. That distinction is important, but the absence of positive evidence after decades of research on respiratory virus interventions is itself a significant finding.

The Vaccine Stops Transmission Claim

On March 29, 2021, CDC Director Rochelle Walensky appeared on MSNBC's The Rachel Maddow Show. She stated, without qualification, that vaccinated people do not carry the virus and cannot spread it to others. The statement was unequivocal. It was also not supported by evidence available at the time, and it was contradicted by CDC's own data within months.¹²

The Provincetown, Massachusetts cluster study, published in CDC's own Morbidity and Mortality Weekly Report on July 30, 2021, documented an outbreak of COVID-19 in which 74 percent of those infected were fully vaccinated. Many of the vaccinated cases showed high viral loads comparable to unvaccinated cases. CDC updated its public guidance on July 27, 2021, to acknowledge that vaccinated people could carry and transmit the virus. The updated guidance arrived four months after the director of the CDC had told the country the opposite on national television.¹³

Natural Immunity: The Science They Chose Not to Follow

An Israeli study published in August 2021, involving data from the Maccabi Healthcare database, compared the protection conferred by natural infection versus two-dose mRNA vaccination. It found that natural immunity was substantially stronger and more durable than vaccine-induced immunity during the study period, with vaccinated individuals who had not been previously infected showing significantly higher risk of symptomatic infection than those who had recovered from COVID-19.¹⁴

A Cleveland Clinic study published in June 2021 similarly found that prior infection provided protection equivalent to or exceeding vaccination among healthcare workers. These findings were not hidden. They were published in peer-reviewed literature and reported in scientific media. They were not incorporated into CDC guidance, which consistently treated the previously infected as though they had no immunity and required vaccination on the same schedule as those with no prior exposure.¹⁵

The suppression of the natural immunity question was not passive. In October 2020, Francis Collins and Anthony Fauci privately discussed the Great Barrington Declaration, a document signed by Dr. Martin Kulldorff of Harvard, Dr. Sunetra Gupta of Oxford, and Dr. Jay Bhattacharya of Stanford, all credentialed academic epidemiologists at the most prestigious institutions in the world. The declaration argued for focused protection of the vulnerable rather than universal lockdowns, and prominently discussed natural immunity as a factor in population-level protection.¹⁶

Collins described these three scientists as fringe epidemiologists in his email to Fauci and called for a quick and devastating published takedown of the declaration. The emails were released through FOIA. Three scientists with appointments at Harvard, Oxford, and Stanford were described by the director of NIH as fringe, in a private communication, while their scientific arguments went publicly unengaged.

The Risk Was Not Equal: Age and the One-Size Mandate

Among the most documented and least publicly discussed facts of the COVID-19 pandemic is the extraordinary variation in risk by age. John Ioannidis of Stanford, one of the world's most cited epidemiologists, published an analysis in the WHO's own Bulletin in October 2020 examining infection fatality rates across age groups derived from seroprevalence data. His findings showed that the infection fatality rate for people under fifty was dramatically lower than for the elderly, and that for healthy children and young adults the risk of death from COVID-19 was comparable to the annual risk from seasonal influenza.¹⁷

This age stratification of risk was known from the earliest weeks of the pandemic. It was not reflected in the uniform policies that followed: universal school closures, vaccine mandates for young workers in low-risk categories, and the political and social pressure applied to young healthy people who questioned whether they personally needed vaccination. The one-size-fits-all approach was a policy choice, not a scientific necessity, and it was a choice made in the face of evidence pointing in a different direction.

Myocarditis in Young Males: The Acknowledged Risk

By the summer of 2021, data emerging from Israel, the United States, and other countries with high vaccination rates began to show an elevated rate of myocarditis, inflammation of the heart muscle, in young males following mRNA vaccination. The signal was particularly pronounced in males between the ages of twelve and thirty following the second dose.

The CDC's Advisory Committee on Immunization Practices discussed this data in multiple meetings throughout 2021 and 2022, and the elevated risk was formally acknowledged in CDC guidance. The CDC confirmed that myocarditis occurred at higher-than-expected rates in young males post-vaccination, while maintaining that the benefits of vaccination outweighed the risks. This risk-benefit calculus may be correct for most populations. It was not transparently communicated to young males and their families during the period when vaccine mandates were being imposed on that demographic.¹⁸

What the Drug Is

Ivermectin is an antiparasitic drug developed in the late 1970s through the collaboration of American scientist William Campbell and Japanese scientist Satoshi Omura. In 2015, Campbell and Omura were awarded the Nobel Prize in Physiology or Medicine for their discovery. The drug has been used by more than four billion people worldwide and has been on the World Health Organization's list of essential medicines since 1987. Its safety profile is, by any reasonable measure, exceptional.¹⁹

The drug is also, as of this writing, being prescribed every day by licensed physicians in the United States and around the world as part of combination protocols for COVID-19. The Front Line COVID-19 Critical Care Alliance, a group of critical care physicians, developed protocols known as I-MASK+ and MATH+ that combine Ivermectin with corticosteroids, zinc, Vitamin D, and other agents. Physicians trained in these protocols have treated thousands of patients.

The FDA Campaign

On August 21, 2021, the Food and Drug Administration published a consumer update on its website titled "Why You Should Not Use Ivermectin to Treat or Prevent COVID-19." The FDA's social media accounts published a post reading: "You are not a horse. You are not a cow. Seriously, y'all. Stop it." The posts referenced the use of veterinary formulations of Ivermectin, conflating those with the human pharmaceutical grade drug that had been approved by the FDA for human use for decades.²⁰

The FDA's authority to issue this kind of directive was subsequently challenged in federal court. In September 2023, the Fifth Circuit Court of Appeals ruled in Physicians for Informed Consent et al. v. Becerra that the FDA had exceeded its statutory authority by directing physicians not to prescribe an approved medication for off-label use. The court held that the FDA is not a physician and has authority to inform and apprise, but not to endorse, denounce, or advise in the manner of personalized medical guidance.²¹ The ruling reinstated the lawsuit and remanded it to the district court; the case was subsequently settled, with the FDA agreeing to remove its ivermectin consumer update and related social media posts. Off-label prescribing is legal, common, and responsible for a substantial fraction of all prescriptions written in the United States. The Fifth Circuit's ruling was legally significant. It received almost no mainstream media coverage.

The Physician Under Threat

Dr. Pierre Kory, a critical care pulmonologist and one of the founders of the FLCCC, testified before the Senate Homeland Security Committee on December 8, 2020, calling for emergency authorization of Ivermectin based on the clinical evidence his team had assembled. His testimony was viewed tens of millions of times after being posted online. YouTube subsequently removed it.²²

In July 2021, the Federation of State Medical Boards issued a statement warning that physicians who spread COVID-19 vaccine misinformation could face suspension or revocation of their medical licenses. The statement did not define misinformation with specificity. It created a direct professional threat to any physician who publicly expressed views that differed from official guidance, including on questions such as natural immunity and Ivermectin efficacy where the scientific literature was genuinely contested.²³

What the Trials Found

The scientific literature on Ivermectin for COVID-19 is genuinely mixed, and intellectual honesty requires saying so. The TOGETHER trial, the largest randomized controlled trial of Ivermectin for COVID-19, published in the New England Journal of Medicine in March 2022, found no statistically significant benefit in the studied population. This is an important result and belongs in any honest accounting.²⁴

It is also true that multiple meta-analyses, including one published in the American Journal of Therapeutics in June 2021, found significant reductions in mortality with Ivermectin treatment.²⁵ Researchers have noted that many of the positive trials came from regions with endemic parasitic infections, and that parasite burden may confound results, since Ivermectin's known antiparasitic effect could reduce COVID-19 severity in populations with high parasite loads independent of any direct antiviral effect.

What the record does not support is the characterization of Ivermectin as a horse dewormer taken by dangerous cranks. That framing was applied to a Nobel Prize-winning drug with a four-billion-dose safety record, being prescribed by licensed physicians with critical care credentials, based on a clinical rationale that is documented in peer-reviewed literature. The FDA was subsequently told by a federal court that it lacked the authority to make that characterization in the manner it did.

The Diagnosis and the Protocol

On September 1, 2021, Joe Rogan posted a video on Instagram announcing that he had tested positive for COVID-19 and describing his treatment protocol. The protocol included Ivermectin, monoclonal antibodies, prednisone, and azithromycin, treatments prescribed by his personal physician. Rogan recovered quickly and was back to work within days. What the coverage of his case largely omitted was that the monoclonal antibody treatment he received was under FDA emergency use authorization at the time. It was approved. His recovery was rapid and complete.²⁶

The media response was immediate and categorical. CNN, MSNBC, and numerous other outlets characterized his treatment as dangerous and irresponsible, focusing almost exclusively on the Ivermectin component while setting aside the FDA-authorized monoclonal antibody treatment and ignoring the fact that a licensed physician had prescribed the entire protocol.

The Green Filter

Rogan noticed something about CNN's coverage that others had also observed. CNN had used footage of him that appeared visibly different from the original. The color had been desaturated and shifted toward a sickly greenish tone, making him appear significantly more ill than the original footage showed. Rogan posted a side-by-side comparison on Instagram: the CNN version on one side, looking drained and unwell, and his original footage on the other, showing a man who looked, as he was, in the process of recovering.

The Gupta Admission

On October 13, 2021, Dr. Sanjay Gupta, CNN's chief medical correspondent, appeared as a guest on The Joe Rogan Experience. Rogan pressed him directly and on the record about the altered footage. Gupta acknowledged, on tape, that CNN should not have done that.²⁷

The admission was significant not because it resolved every dispute between Rogan and CNN, but because it demonstrated that Rogan's factual claim about the footage was correct, that the network's own medical correspondent acknowledged it on the record, and that this acknowledgment received essentially no coverage from the network whose conduct was being discussed.

The Campaign and Its Target

In January 2022, musician Neil Young sent an open letter to Spotify demanding the platform remove The Joe Rogan Experience, citing COVID misinformation. Several other artists followed. Spotify added content advisories to COVID-related episodes but did not remove Rogan's podcast.²⁸

The campaign against Rogan was notable for what it did not engage with. It did not address the specific factual claims he had made that proved to be accurate, including his early skepticism about vaccine effectiveness against transmission, his discussion of natural immunity, and his platform for scientists such as Dr. Robert Malone and Dr. Peter McCullough whose views, while contested, were grounded in credentials and published research. The campaign treated the questions as settled when they were not, and treated the questioner as illegitimate rather than engaging the substance of what he raised.

Chris Cuomo's Private Medicine

Chris Cuomo spent substantial airtime on CNN in 2021 as a prominent voice for the institutional COVID consensus, which included dismissal of Ivermectin as a dangerous and unproven drug. His coverage reflected, amplified, and in some cases went beyond the official FDA and CDC positions on alternative treatments.

In 2023, after leaving CNN and joining NewsNation, Cuomo publicly acknowledged that he had been taking Ivermectin as part of his treatment for post-COVID syndrome. He was being treated by Dr. Pierre Kory of the FLCCC, the same physician whose Senate testimony had been removed from YouTube, whose medical license had been threatened, and whose treatment protocols Cuomo's former network had characterized as dangerous misinformation.²⁹

The gap between Cuomo's public posture and his private medical choices is a matter of documented record. He did not characterize himself as irresponsible or dangerous for taking the drug. He described it as part of a legitimate treatment protocol that was helping him. What he did not do was revisit, publicly and explicitly, the coverage his network had produced when others were making the same choice.

The Dave Smith Exchange

When Smith and Cuomo appeared together on the PBD Podcast, Smith pressed Cuomo directly on his prior statements about Ivermectin. Cuomo denied having spoken disparagingly about the drug. The host then played back a clip of Cuomo and Don Lemon on CNN mocking Ivermectin and calling it a horse dewormer. Cuomo was confronted with his own words on tape.³⁰ The exchange illustrated the central problem with how COVID policy had been communicated to the public: the people who were most visible and authoritative in dismissing alternative treatments were not operating from a position of consistent principle. When Cuomo's own health required it, he made a different choice than the one he had recommended to his audience.

What They Said About the Unvaccinated

The treatment of unvaccinated Americans by a significant portion of the media class during 2021 and into 2022 constitutes a documented record that deserves direct examination. Howard Stern stated on his SiriusXM broadcast that hospitals should turn away unvaccinated patients from ICU beds, framing the unvaccinated as having made a choice that forfeited their claim to medical care.³¹

Jimmy Kimmel, on his ABC late-night program in September 2021, made statements along similar lines, suggesting that hospitals could reasonably inform unvaccinated patients seeking ICU care that no beds were available. The statements were framed as comedy but their substance was a direct argument for medical triage based on vaccination status rather than medical need.³²

What these positions ignored, and what the scientific literature available at the time already showed, was that vaccination status was not a reliable proxy for transmission risk, that natural immunity was real and substantial, that age and health status were the primary determinants of COVID-19 severity, and that the risk-benefit calculus for a healthy twenty-five-year-old was genuinely different from that of a seventy-year-old with comorbidities. The one-size contempt for the unvaccinated was not a scientific position. It was a social one.

The question of natural immunity was not a fringe position. It was the default assumption of immunology for a century. Infection by a pathogen typically produces immune responses including memory T-cells and B-cells and antibodies calibrated to the full antigen profile of the virus rather than to a single spike protein. That broader immune response has historically been associated with more durable protection. These principles were not controversial before 2020.

The Israeli study published in August 2021 examined hundreds of thousands of patients and found that those with prior infection had substantially lower risk of symptomatic COVID-19 than vaccinated individuals without prior infection during the study period. The Cleveland Clinic study of healthcare workers found that those who had been previously infected and were unvaccinated had COVID-19 rates no higher than vaccinated individuals with no prior infection. These were large studies, from credible institutions, published in peer-reviewed literature.

The policy implication of this data was significant and was not followed. Individuals who had recovered from COVID-19, and who had documented immunity, were subjected to the same mandates as those with no prior exposure. Many lost jobs, access to venues, and their standing in institutional settings for declining a vaccination that the available evidence suggested they did not need at the level of personal risk reduction, and that carried its own documented risk of myocarditis in their demographic.

Ioannidis's work on age-stratified infection fatality rates, published in the WHO's own Bulletin, showed that for healthy individuals under fifty, the infection fatality rate of COVID-19 was in the range of seasonal influenza or lower. This did not mean COVID-19 was harmless. It meant that the risk was not uniformly distributed, and that policies designed for the most vulnerable were not necessarily appropriate for the least vulnerable. That distinction was not made clearly in public communication, and those who made it were frequently characterized as minimizing the pandemic rather than accurately describing its epidemiology.

The NIH, Moderna, and the Patent Dispute

The COVID-19 pandemic produced, among its many consequences, extraordinary financial transfers to pharmaceutical companies. Moderna's mRNA-1273 vaccine generated tens of billions of dollars in revenue in 2021 and 2022 alone. What was less prominently reported was the nature of the relationship between Moderna and the federal agency most responsible for recommending its vaccine to the American public.

NIH scientists played a documented role in designing the stabilized spike protein technology used in the mRNA-1273 vaccine, and the federal government filed multiple patent applications listing federal scientists as co-inventors.³³ Moderna subsequently disputed NIH's co-inventorship claim on the primary mRNA sequence patent, leading to a public disagreement in which NIH Director Francis Collins called Moderna's position a major mistake. The NIH itself stated that it did not co-own the vaccine. The dispute over inventorship and potential royalties remained unresolved for an extended period. Whether or not co-ownership was ultimately established, the structural proximity between the agency issuing vaccine guidance and the company manufacturing the vaccine raises legitimate conflict of interest questions that received insufficient public scrutiny.

Remdesivir and the Standard of Care Decision

In May 2020, Anthony Fauci announced at a White House briefing that Remdesivir, an antiviral drug manufactured by Gilead Sciences, would become the new standard of care for hospitalized COVID-19 patients. The announcement was based on a preliminary trial. Gilead's stock rose substantially. The drug became widely used in American hospitals.³⁴

In December 2020, the WHO's Solidarity trial, a large multi-country randomized controlled trial published in the New England Journal of Medicine, found that Remdesivir had little or no effect on mortality, length of hospital stay, or need for mechanical ventilation. The drug that had been declared the standard of care by the director of NIAID was found by the largest trial conducted on it to be essentially ineffective.³⁵

Daszak and the Organization That Funded the Research

Peter Daszak's EcoHealth Alliance received millions of dollars in NIH funding to conduct bat coronavirus research at the Wuhan Institute of Virology. Daszak personally organized the Lancet letter that dismissed the lab leak hypothesis as a conspiracy theory without disclosing his organization's direct financial relationship with WIV. He was appointed to the Lancet's COVID-19 Commission, a body tasked with investigating the pandemic's origins, and eventually resigned from it under pressure regarding his conflicts of interest.³⁶

EcoHealth Alliance's IRS Form 990 filings, publicly available through ProPublica's Nonprofit Explorer, document the organization's revenue, its NIH grants, and Daszak's compensation. The House Select Subcommittee on the Coronavirus Pandemic examined EcoHealth Alliance's activities extensively in 2023 and 2024, and the documentary record of what the organization funded, what it reported to NIH, and what it failed to report is now substantially in the public domain.

What this article has documented is not a conspiracy. It is something more mundane and more troubling: a set of institutions operating according to their financial and professional interests in a manner that systematically suppressed legitimate scientific debate during a public health crisis.

The lab leak hypothesis was not allowed to be discussed because the people who organized the discussion against it had financial interests in the alternative conclusion. Ivermectin could not be prescribed without professional risk because the FDA, whose authority was subsequently ruled by a federal appellate court to have been exceeded, issued guidance that threatened the licenses of physicians who deviated from it. Natural immunity could not be acknowledged as a legitimate basis for policy because doing so would complicate the universal vaccination mandate that the institutions had committed to.

The scientists who asked these questions were not cranks. Kulldorff, Gupta, and Bhattacharya were from Harvard, Oxford, and Stanford. Ioannidis is one of the most cited scientists in the world. Kory was a practicing critical care physician who had treated COVID-19 patients in the ICU. The questions they raised were not resolved by evidence. They were resolved by institutional pressure, career threat, and the weaponization of the word misinformation against positions that had legitimate scientific grounding.

The Fifth Circuit ruling, which received almost no mainstream coverage, stated plainly that the FDA cannot direct physicians how to prescribe approved medicines. A federal court said that. After years during which physicians lost hospital privileges and faced license threats for prescribing a Nobel Prize-winning drug with four billion doses of safety data, a court said the FDA did not have the authority to stop them.

The documents exist. The court rulings exist. The FOIA emails exist. The congressional testimony exists alongside the letters that contradicted it. The question is not whether the evidence is available. The question is whether enough people will demand that their institutions be held to the same standard of honesty they were told to apply to themselves.